Schwartz Aharon (CIK 1625184) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-09-04). Recent activity: Buy PLX (7,500 shares), Buy PLX (129,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-04 | Protalix BioTherapeutics, Inc. (PLX) | Director | Buy | 7,500 | $0 |
| 2025-08-12 | Protalix BioTherapeutics, Inc. (PLX) | Director | Buy | 129,000 | $206,400 |
Source: SEC Form 4 filings · as of 2025-09-04